Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review

@article{Luime2010DoesAC,
  title={Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review},
  author={J. Luime and E. Colin and J. Hazes and E. Lubberts},
  journal={Annals of the Rheumatic Diseases},
  year={2010},
  volume={69},
  pages={337 - 344}
}
  • J. Luime, E. Colin, +1 author E. Lubberts
  • Published 2010
  • Medicine
  • Annals of the Rheumatic Diseases
    • Objective: To review the diagnostic and prognostic value of anti-mutated citrullinated vimentin (MCV) in rheumatoid arthritis, taking into account the already available serology. Methods: Medline was searched via PubMed (1966 to May 2008) for anti-MCV and related terms, arthritis and arthropathies. Studies with anti-MCV, arthritis/arthropathy, and primary data on diagnosis and/or prognosis were included. Their methodological quality was assessed using the Quality Assessment of Diagnostic… CONTINUE READING
    View on BMJ
    ard.bmj.com
    74 Citations
    Highly Influential Citations
    4
    Background Citations
    22
    Methods Citations
    2
    Results Citations
    5

    Paper Mentions

    Observational Clinical Trial
    Diagnostic Value of Anti-MCV in Pts With RA
    The aim of this work is to evaluate the diagnostic value of anti-MCV antibodies in rheamatoid arthritis patients and to correlate its relationtion disease activity and manifestations… Expand
    ConditionsAnti-MCV in Rheamatoid Arthritis
    InterventionDiagnostic Test
    Assiut University
    September 2017 - February 2019
    74 Citations
    Citation Type

    Citation Type

    Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study
    • 122
    • PDF
    Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?
    • 7
    • PDF
    Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    • 51
    • Highly Influenced
    • PDF
    Anti-Mutated Citrullinated Vimentin (Anti-MCV) Antibodies as a Diagnostic Aid for Rheumatoid Arthritis
    • 3
    • PDF
    Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.
    • 27
    Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis
    • 9
    Antibodies to Mutated citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial skeleton Affection
    Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis
    • 1
    • PDF
    Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial Skeleton Affection
    • 24
    • PDF
    Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial Skeleton Affection Rheumatology and Rehabilitation And

      References

      SHOWING 1-10 OF 77 REFERENCES
      Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
      • 208
      Comparison of Anti-mutated Citrullinated Vimentin with Anti-cyclic Citrullinated Peptide and Rheumatoid Factors for the Diagnostic Value of Rheumatoid Arthritis
      • 7
      • PDF
      Antibodies to Citrullinated Vimentin are a Specific and Sensitive Marker for the Diagnosis of Rheumatoid Arthritis
      • 65
      Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
      • 84
      Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
      • 278
      Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
      • 134
      Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis
      • 42
      Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
      • 112
      • Highly Influential
      • PDF
      Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis.
      • 31
      Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
      • 85
      • Highly Influential